Comparison between Purv Flexipack IPO and Zenith Drugs IPO.
Purv Flexipack IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Purv Flexipack IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Holani Consultants Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Holani Consultants Pvt.Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Purv Flexipack IPO is up to ₹37.74 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Purv Flexipack IPO is ₹71.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Purv Flexipack IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹70.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹71.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹71.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 53,15,200 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹37.74 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 53,15,200 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹37.74 Cr | up to ₹33.94 Cr |
Purv Flexipack IPO opens on Feb 27, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Purv Flexipack IPO and Zenith Drugs IPO is Feb 29, 2024, and Feb 22, 2024, respectively.
| Purv Flexipack IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 26, 2024 | Feb 16, 2024 |
| Issue Open | Feb 27, 2024 | Feb 19, 2024 |
| Issue Close | Feb 29, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Mar 01, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Mar 04, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Mar 04, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Mar 05, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 31, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | May 30, 2024 | May 23, 2024 |
Purv Flexipack IPO P/E ratio is 13.17, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Purv Flexipack IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.17 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.98 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.17 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹148.98 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 11.46% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 18.50% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.62 | 1.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.39 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.84% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Purv Flexipack IPO Retail Individual Investors (RII) are offered 19,00,800 shares while in Zenith Drugs IPO retail investors are offered 19,00,800 shares. Qualified Institutional Buyers (QIB) are offered 10,52,800 shares in Purv Flexipack IPO and 8,59,200 shares in Zenith Drugs IPO.
| Purv Flexipack IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reservation | 15,16,800 shares | 12,88,000 shares |
| Market Maker Reservation | 3,48,800 shares | 8,52,800 shares |
| QIB | 10,52,800 shares | 8,59,200 shares |
| NII | 8,44,800 shares | 6,44,800 shares |
| RII | 19,00,800 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 53,15,200 shares | 42,96,000 shares |
Purv Flexipack IPO subscribed 421.78x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Purv Flexipack IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 157.32x | 106.72x |
| NII (times) | 690.72x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 448.73x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 421.78x | 179.18x |
